GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (FRA:9VC) » Definitions » Investments And Advances

ATAI Life Sciences NV (FRA:9VC) Investments And Advances : €113.17 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is ATAI Life Sciences NV Investments And Advances?

ATAI Life Sciences NV's Investments And Advances for the quarter that ended in Mar. 2024 was €113.17 Mil.

ATAI Life Sciences NV's quarterly Investments And Advances increased from Sep. 2023 (€70.43 Mil) to Dec. 2023 (€84.06 Mil) and increased from Dec. 2023 (€84.06 Mil) to Mar. 2024 (€113.17 Mil).

ATAI Life Sciences NV's annual Investments And Advances declined from Dec. 2021 (€24.57 Mil) to Dec. 2022 (€6.38 Mil) but then increased from Dec. 2022 (€6.38 Mil) to Dec. 2023 (€84.06 Mil).


ATAI Life Sciences NV Investments And Advances Historical Data

The historical data trend for ATAI Life Sciences NV's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ATAI Life Sciences NV Investments And Advances Chart

ATAI Life Sciences NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
20.65 6.61 24.57 6.38 84.06

ATAI Life Sciences NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.46 3.68 70.43 84.06 113.17

ATAI Life Sciences NV Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


ATAI Life Sciences NV (FRA:9VC) Business Description

Traded in Other Exchanges
Address
Wallstraße 16, Berlin, BB, DEU, 10179
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

ATAI Life Sciences NV (FRA:9VC) Headlines

No Headlines